GlycoMimetics Inc (GLYC)
0.2337
+0.03
(+13.72%)
USD |
NASDAQ |
Dec 20, 16:00
0.23
0.00 (0.00%)
After-Hours: 20:00
GlycoMimetics Total Liabilities (Quarterly): 4.322M for Sept. 30, 2024
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
Biomarin Pharmaceutical Inc | 1.438B |
Arbutus Biopharma Corp | 33.55M |
Revance Therapeutics Inc | 624.59M |
FibroGen Inc | 466.12M |
Cidara Therapeutics Inc | 46.70M |
Total Liabilities (Quarterly) Related Metrics
Total Assets (Quarterly) | 15.70M |
Shareholders Equity (Quarterly) | 11.38M |